Cardiovascular Effects of Medications for the Treatment of Attention-Deficit Hyperactivity Disorder: What is Known and How Should it Influence Prescribing in Children?

Author： Elia Josephine   Vetter Victoria L.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.12, Iss.3, 2010-06, pp. : 165-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Antipsychotics on the Unborn Child: What Is Known and How Should This Influence Prescribing?

By Pinkofsky H.B.  

Pediatric Drugs, Vol. 2, Iss. 2, 2000-03 ,pp. : 83-90

Adis International

Access to resources Recommend Favorite

Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder

By Stiefel Gary  

Drug Safety, Vol. 33, Iss. 10, 2010-10 ,pp. : 821-842

Adis International

Access to resources Recommend Favorite

Teratogenic Potential of the Newer Antiepileptic Drugs: What is Known and How Should This Influence Prescribing?

By Palmieri C.   Canger R.  

CNS Drugs, Vol. 16, Iss. 11, 2002-01 ,pp. : 755-764

Adis International

Access to resources Recommend Favorite

Effect of Over-the-Counter Drugs on the Unborn Child: What is Known and How Should This Influence Prescribing?

By Kacew S.  

Pediatric Drugs, Vol. 1, Iss. 2, 1999-04 ,pp. : 75-80

Adis International

Access to resources Recommend Favorite

SSRIs and Upper Gastrointestinal Bleeding: What is Known and How Should it Influence Prescribing?

By Dalton Susanne O.  

CNS Drugs, Vol. 20, Iss. 2, 2006-01 ,pp. : 143-151

Adis International

Access to resources Recommend Favorite